Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Apple Inc. (AAPL), Netflix, Inc. (NFLX): An Easy Way To Find Great Buys In A Bad Market

Page 1 of 2

Nobody ever believes me when I tell them this is probably the best way to find great stocks.

My trick is to use Wall Street’s army of thousands of analysts.

They’ve led to relative easy gains as high as 810% in the past few years. Honestly.

And best of all, they’re continuing to do it even as the markets are showing the greatest signs of weakness in years.

It’s not the way you’re probably thinking, though. Here’s how to do it.

Wall Street’s Best-Kept Secret Exposed
You see, most Wall Street analysts are truly awful at their jobs.

And I mean awful.

A recent analysis of Wall Street analysts’ “buy” and “sell” recommendations shows how you can turn these high-priced suits into safe, consistent gains.

The research found that between 2008 and 2012 investors could have made a fortune by doing one simple thing — the exact opposite of what Wall Street says.

Let me explain…

Had you bought the 10 stocks Wall Street rated the highest at the beginning of each year, you would have lost an average 11% per year.

But you could have almost doubled the market by buying the most disliked stocks on Wall Street (the ones the analysts assign “sell” ratings to). If you bought what Wall Street told you to “sell,” you would have made an average of 16% each year.

Those are just the averages though. If you’re an active investor who uses Wall Street’s “sell” recommendations as a starting point, you can truly make a fortune.

Difference Between A 52% Loss And A 810% Gain
One of my favorite examples of how bad Wall Street analysts’ ratings are comes from one of the most successful companies of the last five years.

Netflix, Inc. (NASDAQ:NFLX)

I’m talking about Netflix, Inc. (NASDAQ:NFLX).

Not everyone always saw the Netflix, Inc. (NASDAQ:NFLX) story playing out as well as it has.

Wall Street sure didn’t see it either. In fact, they probably couldn’t have played it worse if they tried.

Look at Oppenheimer & Co., a 120-year-old money management and research firm on Wall Street with more than $160 billion under management, to see how not to play a major growth story.

Oppenheimer’s research department initiated coverage on Netflix, Inc. (NASDAQ:NFLX) with a “buy” rating in May 2009. The stock was $40 at the time.

Two months later Oppenheimer downgraded Netflix from a “buy” to “sell” when it was $42.

They gave investors a solid two-month 5% gain. Not bad. But what they missed out on was truly great.

Since Oppenheimer said “sell,” Netflix shares went on to climb from $42 to $175 in the next 15 months.

But the surging run in Netflix, Inc. (NASDAQ:NFLX) wasn’t something Oppenheimer was willing to miss out on. Oppenheimer reversed its position and said “buy” after Netflix shares quadrupled.

Netflix shares continued to rise for a while. But then they turned down fast. Netflix shares fell, fell some more, and then fell some more. They ended up falling below $70. Oppenheimer kept the “buy” rating on them the whole time.

After watching shares fall more than 50%, Oppenheimer decided to cut its losses. It recommended “sell” on Netflix, Inc. (NASDAQ:NFLX) around $80 per share.

Since then Netflix, Inc. (NASDAQ:NFLX) shares have more than doubled again, recently trading for $210 each. That’s more than doubling again after the latest “sell.”

Here’s a chart showing all the action:

It’s tough to imagine worse timing, right? But what’s really worse are the costs.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!